Skip to main content
European Commission logo print header

Natural antimony resistance in leishmania donovani: a fundamental study to guide future epidemiological strategies

Obiettivo

Control of leishmaniasis is being challenged by the emergence of natural resistance against the first line treatment - pentavalent antimonials (SbV). Monitoring and prevention of the spreading of drug resistance is now a priority for the control of leishmaniasis.

In order to design and develop the required epidemiological tools, it is essential to understand the mechanism of natural SbV resistance and to gain insights into the dynamics of the emergence and/or spreading of drug resistance.

Within this context a multidisciplinary fundamental study is required to gain a comprehensive understanding of the natural SbV-resistance phenotype, including molecular basis, biochemical profile, and effect on parasite survival.

Invito a presentare proposte

FP6-2005-MOBILITY-5
Vedi altri progetti per questo bando

Coordinatore

UNIVERSITY OF GLASGOW
Contributo UE
Nessun dato
Indirizzo
University Avenue
GLASGOW
Regno Unito

Mostra sulla mappa

Collegamenti
Costo totale
Nessun dato